UK hails blood pressure findings
TAKING repeated blood pressure readings over a 24-hour period rather than a one-off measurement in the clinic is the most cost-effective way of deciding who should be prescribed drugs for hypertension, according to a study published yesterday.
The findings in favor of so-called ambulatory blood pressure monitoring were immediately adopted by the UK's health costs watchdog, the National Institute for Health and Clinical Excellence, in new guidelines on how to diagnose and when to treat high blood pressure.
Bryan Williams, a professor of medicine at Leicester University and chairman of the NICE guideline development group, said the change would affect the treatment of millions of people and was "a step-change likely to be replicated across the world."
Richard McManus, of Birmingham University, who led the study published in The Lancet medical journal which prompted the guideline change, said: "Ambulatory monitoring allows better targeting of blood pressure treatment. It is cost-saving in the long term as well as more effective."
About 1 billion people worldwide have high blood pressure, a major risk factor in cardiovascular disease.
The findings in favor of so-called ambulatory blood pressure monitoring were immediately adopted by the UK's health costs watchdog, the National Institute for Health and Clinical Excellence, in new guidelines on how to diagnose and when to treat high blood pressure.
Bryan Williams, a professor of medicine at Leicester University and chairman of the NICE guideline development group, said the change would affect the treatment of millions of people and was "a step-change likely to be replicated across the world."
Richard McManus, of Birmingham University, who led the study published in The Lancet medical journal which prompted the guideline change, said: "Ambulatory monitoring allows better targeting of blood pressure treatment. It is cost-saving in the long term as well as more effective."
About 1 billion people worldwide have high blood pressure, a major risk factor in cardiovascular disease.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.